Oxford, UK (15 August, 2023) – Refeyn®, the leading global manufacturer of mass photometry instruments and technology, has unveiled its latest innovation, a software package designed to expand the use ...
Antibody aggregation severely impacts a biopharmaceutical product’s efficacy and safety. Hence, an array of techniques are used to assess the physiochemical stability of candidate therapeutic ...
Refeyn, expands its global adoption across contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs). To showcase this development, Refeyn has launched a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results